IP Library Granted Patent US 9,938,312
Granted Patent B2
US 9,938,312 · App. 14/005,036 · Granted Apr 10, 2018

Compounds and methods for chemical and chemo-enzymatic synthesis of complex glycans

Inventors: Geert-Jan Boons (Athens, GA); Zhen Wang (Arlington, MA)
Assignee: University of Georgia Research Foundation, Inc.
C07H13/04C07H15/18
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,938,312
App. No.
14/005,036
Granted
Apr 10, 2018
Kind
B2
Abstract

The present invention provides chemical and chemo-enzymatic methods for the synthesis of a wide array of complex asymmetric multi-antennary glycans.

Claims (25)

1. An orthogonally protected branched oligosaccharide having the formula (I):

wherein each of R 1 , R 4 , R 6 and R 8 is independently an orthogonal protecting group or a permanent protecting group, provided that at least two of R 1 , R 4 , R 6 and R 8 are orthogonal protecting groups;

each of R 2 , R 3 , R 5 , R 7 , and R 10 is independently a permanent protecting group;

R 9 is an orthogonal protecting group, a permanent protecting group, or a glucosamine moiety;

X is —OR 15 or —SR 16 ;

R 15 is H, alkyl, cycloalkyl, substituted alkyl or cycloalkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, aryl or substituted aryl; a protecting group; an anomeric spacer or linker; a fluorous tag; or a leaving group; and

R 16 is H, alkyl, cycloalkyl, substituted alkyl or cycloalkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, aryl, or substituted aryl.

2. The orthogonally protected oligosaccharide of claim 1 further comprising a glycosidically linked glucosamine moiety in place of X, wherein the ring hydroxyls on the glucosamine moiety are protected, wherein the amine at the C-2 position of the glucosamine moiety is protected, and wherein the anomeric position at the reducing end of the glucosamine moiety comprises X as in formula (I).

3. The orthogonally protected oligosaccharide of claim 1 further comprising a glycosidically linked glucosamine disaccharide in place of X, wherein the ring hydroxyls on the glucosamine disaccharide are protected, wherein the amines at both C-2 positions of the glucosamine disaccharide are protected, and wherein the anomeric position at the reducing end of the glucosamine disaccharide comprises X as in formula (I).

4. The orthogonally protected oligosaccharide of claim 2 comprising a glycosidically linked fucose moiety at position C-6 of the terminal reducing glucosamine.

5. The orthogonally protected oligosaccharide of claim 1 wherein the orthogonal protecting group is selected from the group consisting of levulinoyl (Lev); 9-fluorenylmethoxycarbonyl (Fmoc); allyloxycarbonyl (Alloc); 2-naphthylmethyl (Nap); 1-naphthylmethyl (1-Nap); benzoyl (Bz); difluorobenzoyl (dfBz); pivaloyl levulinoyl (PivLev); pivaloyl benzoyl (PivBz); para-methoxybenzyl ether (PMB); methoxy phenyl ether (MP); allyl ether (Allyl); chloroacetyl ester (ClAc); trichloroacetyl ester (Cl 3 Ac), trifluoroacetyl ester (F 3 Ac); and a silyl ether.

6. A method for making an oligosaccharide comprising:

deprotecting the orthogonally protected oligosaccharide of claim 1 by removing an orthogonal protecting group to yield a deprotected glycosyl acceptor; and

linking the deprotected glycosyl acceptor to a glycosyl donor to yield an extended oligosaccharide.

7. The method of claim 6 wherein the glycosyl donor is a protected or masked glucosamine or a lactosamine.

8. The method of claim 6 wherein the extended oligosaccharide comprises 4, 5, 6, 7, 8, 9, 10, 11, 12, 13 or 14 monosaccharide units.

9. The method of claim 6 wherein the extended oligosaccharide is a multi-antennary glycan comprising two, three, four or five branches.

10. The method of claim 6 comprising sequentially removing orthogonal protecting groups from the orthogonally protected oligosaccharide.

11. The method of claim 10 further comprising removing permanent protecting groups to yield a deprotected multi-antennary glycan.

12. The method of claim 11 wherein the multi-antennary glycan is asymmetric.

13. The method of claim 12 wherein the deprotected multi-antennary glycan is masked at at least one position.

14. The method of claim 12 further comprising contacting the asymmetric multi-antennary glycan with a first carbohydrate processing enzyme under conditions to yield an enzymatically extended multi-antennary glycan.

15. The method of claim 14 comprising unmasking the enzymatically extended multi-antennary glycan to yield an unmasked multi-antennary glycan, followed by contacting the unmasked multi-antennary glycan with a second carbohydrate processing enzyme under conditions to yield a multi-antennary glycan that is further extended.

16. The method of claim 15 further comprising sequentially contacting the extended multi-antennary glycan with at least one additional carbohydrate processing enzyme under conditions to further extend the multi-antennary glycan.

17. The orthogonally protected oligosaccharide of claim 3 comprising a glycosidically linked fucose moiety at position C-6 of the terminal reducing glucosamine.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 2, 2013
From: BOONS, GEERT-JAN; WANG, ZHEN
To: UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.
Reel/Frame 031332/0174 →
CONFIRMATORY LICENSE Recorded Sep 27, 2013
From: UNIVERSITY OF GEORGIA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 031305/0335 →
Continuity (2)
Provisional Application 61467661 · Mar 25, 2011
Related Publication 20140051603A1 · Feb 20, 2014